In support of this, combined inhibition of EGF-R and IGF-1R by Gefitinib (Iressa) and AG1024, respectively, resulted in additive to synergistic inhibition of growth and induction of apoptosis in breast cancer cell lines (Camirand et al. 2005). Here, EGFR is linked to breast cancer.